2_2248410_NOI.pdf
PDF 116 KB Posted
- Solicitation number
- NOI-NIAID-25-2248410
About this file
This is a Pre-solicitation Notice (NOI-NIAID-25-2248410) from the National Institute of Allergy and Infectious Diseases (NIAID) announcing their intent to negotiate on a sole-source basis with the University of Washington for qRT-PCR Testing Analysis services. The requirement involves testing approximately 2,800 blood samples from a Malaria Infection Biology and Immunity Unit's L9LS monoclonal antibody clinical trial conducted in Mali.
The period of performance is January 1, 2024 through December 31, 2025, with work to be performed in Rockville, MD. The University of Washington laboratory will perform the only FDA-qualified Drug Development Tool Biomarker qRT-PCR assay for detecting and quantifying Plasmodium parasites. While this is a notice of intent for sole-source award, interested parties may submit capability statements through the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 6, 2024, at 10:00 am. Billing will be conducted monthly or quarterly in arrears. The NAICS code is 541380.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 1_2248410_Univ. of Washington Testing Service_PSM.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
PRE-SOLICITATION NOTICE
ID: NOI-NIAID-25-2248410
Post Date: November 26, 2024 Response Date: December 6, 2024
NAICS: 541380
This is a Notice of Intent, NOT a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with the University of Washington for this requirement to perform qRT-PCR Testing Analysis on approximately 2,800 blood samples for the Malaria Infection Biology and Immunity Uni’s L9LS monoclonal antibody clinical trail conducted in Mali. The University of Washington laboratory will perform the only qRT-PCR assay for the detection and quantification of Plasmodium parasites that has received the Drug Development Tool Biomarker Qualification through the FDA.
Description of need:
• qRT-PCR Testing analysis; batched Mali blood sample testing submission (approx. 2800- 3000) per sample
• Billing to be monthly or quarterly in arrears
Period of Performance: 1/01/2024-12/31/2025
Place of Performance Rockville, MD 20852
The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement. All required documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov by December 6, 2024 10:00 am. All vendors must register in the eSASS system to submit their documentation. Instructions on how to register /submit documents are included on the website. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
https://esass.nih.gov/
File details come from the government source that posted it. Updated .